Lennham Pharmaceuticals Expands Leading Psilocybin Patent Portfolio with Addition of New Patent Family

Previous
Previous

Lennham Pharmaceuticals Announces Discovery of Next Generation Testosterone Candidate

Next
Next

Lennham Presents Topline Data From Human PK Study of D9-Caffeine vs Caffeine at ISSN 2021